CLINICAL_TRIALS
trial_result
· 2022-12-21
Clinical Trial Update: Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis [Phase 4]
Summary
Phase 4 trial investigating Staphylococcus aureus and skin microbiome dynamics during flare and resolution in atopic dermatitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Jacob Pontoppidan Thyssen | Conditions: Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Status: UNKNOWN